Summary
This study was undertaken to evaluate the effects of acute pressure overload on prostacyclin (PGI2) release and the influences of 15-hydroperoxy-eicosatetraenoic acid (15-HPETE), an inhibitor of PGI2 synthetase, and indomethacin, an inhibitor of cyclo-oxygenase, in canine hearts. Gradual stenosis of the ascending aorta was performed in 24 anesthetized open-chest dogs. The mongrel dogs were divided into three groups, which received indomethacin, 15-HPETE, and no drug. Changes in the hemodynamics, regional myocardial blood flow (MBF) by the method of H2 gas clearance, and plasma immunoreactive 6-keto-prostaglandin (PG) F1α level in the descending aorta (AO) and great cardiac vein (GCV) were measured. Five minutes after aortic stenosis, the plasma immunoreactive 6-keto-PGF1α level in the GCV and MBF increased from 162±23 to 289±37 pg/ml and from 87±5 to 107±8 ml/min/100 g, respectively, and the calculated coronary vascular resistance (CVR) decreased significantly from 0.93±0.08 to 0.77±0.08 mmHg/ml/min/100 g. These significant changes persisted thereafter. Continuous infusion of 15-HPETE (66 pg/kg/min) into the coronary artery simultaneously prevented significant changes in MBF and the plasma immunoreactive 6-keto-PGF1α level in the GCV and CVR. Intravenous infusion of indomethacin (5 mg/kg), on the other hand, induced a significant decrease in the plasma immunoreactive 6-keto-PGF1α level in both the GCV and AO; significant changes in MBF 5 to 15 min after aortic stenosis and CVR were not affected. From these results, it is suggested that PGI2 plays an important role in the regulation of coronary blood flow in canine hearts with acute pressure overload. In addition, 15-HPETE rather than cyclo-oxygenase inhibitors was found to be beneficial in accurately determining the physiological activities of endogenous PGI2.
Similar content being viewed by others
References
Vatner SF, Higgins CB, Braunwald E (1974) Effects of norepinephrine on coronary circulation and left ventricular dynamics in the conscious dog. Circ Res 34: 812–823
Sullivan JM, Gorlin R (1967) Effect of 1-epinephrine on the coronary circulation in human subjects with and without coronary artery disease. Circ Res 21: 919–923
Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47: 807–813
Needleman P, Kaley G (1978) Cardiac and coronary prostaglandin synthesis and function. N Engl J Med 298: 1122–1128
Dusting GJ, Moncada S, Vane JR (1979) Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systems. Prog Cardiovasc Dis 21: 405–430
Rubio R, Berne RM (1975) Regulation of coronary blood flow. Prog Cardiovasc Dis 18: 105–122
Sivakoff M, Pure E, Hsueh W, Needleman P (1979) Prostaglandins and the heart. Fed Proc 38: 78–82
Schror K (1981) Possible role of prostaglandins in the regulation of coronary blood flow. Basic Res Cardiol 76: 239–249
Newman WH, Frankies MB, Halushka PV (1983) Increased myocardial release of prostacyclin in dogs with heart failure. J Cardiovasc Pharmacol 5: 194–201
Hintze TH, Kaley G (1977) Prostaglandins in the control of blood flow in the canine myocardium. Circ Res 40: 313–320
Giles RW, Wilcken DEL (1977) Reactive hyperaemia in the dog heart: Inter-relations between adenosine, ATP, and aminophylline and the effect of indomethacin. Cardiovasc Res 11: 113–121
Dai XZ, Bache RJ (1984) Effect of indomethacin on coronary blood flow during graded treadmill exercise in the dog. Am J Physiol 247: H452-H458
Aukland K, Bower BF, Berliner RW (1964) Measurement of local blood flow with hydrogen gas. Circ Res 14: 164–187
Koyama T (1975) Local myocardial blood flow measured by the use of a needle-type Pt-H2 electrode. In: Roy PE, Rona G (eds) Recent advances in studies on cardiac structure and metabolism, vol. 10. University Park, Baltimore, pp 525–538
Matsubara T, Itoh K, Nanki M, Nishimura K, Kambe T, Sugiyama S, Ozawa T, Sakamoto N (1983) Relationship between regional myocardial blood flow and mitochondrial function. Basic Res Cardiol 78: 706–715
Kety SS (1960) Theory of blood-tissue exchange and its application to measurement of blood flow. In: Methods in medical research, vol. 8. Brunner HD. ed., Year Book, Chicago, pp 223–227
Marcus ML. ed (1983) The coronary circulation in health and disease. McGraw-Hill, New York, pp 93–111
Hennam JF, Johnson DA, Newton JR, Collins WP (1974) Radioimmunoassay of prostaglandin F2α in peripheral venous plasma from men and women. Prostaglandins 5: 531–542
Caldwell BV, Burstein S, Brock WA, Speroff L (1971) Radioimmunoassay of the F prostaglandins. J Clin Endocr 33: 171–175
Christ-Hazelhof E, Nugteren DH (1981) Prostacyclin is not a circulating hormone. Prostaglandins 22: 739–746
Blair IA, Barrow SE, Waddell KA, Lewis PJ, Dollery CT (1982) Prostacyclin is not a circulating hormone in man. Prostaglandins 23: 579–589
Machin SJ, Chamone DAF, Defreyn G, Vermylen J (1981) The effect of clinical prostacyclin infusions in advanced arterial disease on platelet function and plasma 6-keto-PGF1α . Br J Haematol 47: 413–422
Sakai K, Ito T, Ogawa K (1982) Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart. J Cardiovasc Pharmacol 4: 129–135
LaMorgese J, Fein JM, Shulman K (1975) Polarographic and microsphere analysis of ultraregional cerebral blood flow rates in the cat. In: Harper M, Jennet B, Miller D (eds) Blood flow and metabolism in the brain. Churchill-Livingstone, Edinburgh, pp 7.3–7.8
Woodman OL, Dusting GJ, Nolan RD (1983) Pericardial release of prostacyclin induced by bradykinin and angiotensin II: Effects on coronary blood flow in the dog. J Cardiovasc Pharmacol 5: 954–960
Chazov EI, Pomoinetsky VD, Geling NG, Orlova TR, Nekrasova AA, Smirnov VN (1979) Heart adaptation to acute pressure overload: An involvement of endogenous prostaglandins. Circ Res 45: 205–211
Laustiola K. Seppälä E, Nikkari T, Vapaatalo H (1984) Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: Effect ofβ-adrenergic blockade. J Cardiovasc Pharmacol 6: 449–454
Alexander RW, Kent KM, Pasano JJ (1975) Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart. J Clin Invest 55: 1174–1181
Toda N (1980) Responses to prostaglandins H2 and I2 of isolated dog cerebral and peripheral arteries. Am J Physiol 238: H111-H117
Bourgain RH (1980) The inhibition of PGI2 synthetase within the arterial wall by 15-hydroperoxyarachidonic acid enhances local white platelet thrombosis. Haemostasis 9: 345–351
Hong SL, Carty T, Deykin D (1980) Tranylcypromine and 15-hydroperoxyarachidonate affect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells. J Biol Chem 255: 9538–9540
Koide T, Neichi T, Takato M, Matsushita M, Sugioka K, Nakano M, Hata S (1982) Possible mechanisms of 15-hydroperoxyarachidonic acid-induced contraction of the canine basilar artery in vitro. J Pharmacol Exp Ther 221: 481–488
Moncada S, Gryglewski RJ, Bunting S, Vane JR (1976) A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins 12: 715–733
Trachte G, Lefer A, Aharony D, Smith B (1979) Potent constriction of cat coronary arteries by hydroperoxides of arachidonic acid and its blockade by anti-inflammatory agents. Prostaglandins 18: 909–914
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Imaizumi, M., Ito, Y., Ito, T. et al. Effects of acute pressure overload on prostacyclin release and myocardial blood flow in canine hearts: Inhibition of prostacyclin synthesis with 15-hydroperoxy-eicosatetraenoic acid. Heart Vessels 3, 14–20 (1987). https://doi.org/10.1007/BF02073642
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02073642